SGC, HitGen collaborate on DEL technology for drug discovery

By NS Healthcare Staff Writer

29 Sep 23

HitGen will leverage its DNA-encoded library (DEL) technology platform for the collaboration, specifically the OpenDEL solution, a self-service…

Patient CarePharmaceuticals and Medicines

Amicus gets FDA approval for Pombiliti + Opfolda to treat Pompe disease

By NS Healthcare Staff Writer

29 Sep 23

The FDA has cleared the muscle disorder therapy only for adult LOPD patients whose weight is ≥40kg and…

Patient CarePharmaceuticals and Medicines

Scynexis recalls Brexafemme tablets over potential cross contamination risk

By NS Healthcare Staff Writer

29 Sep 23

Scynexis has recalled the drug over potential risk of cross contamination with a non-antibacterial ß-lactam drug substance in…

Patient CarePharmaceuticals and Medicines

FDA approves Fabre-Kramer’s Exxua for major depressive disorder

By NS Healthcare Staff Writer

29 Sep 23

The drug’s mechanism of targeted single serotonin (5HT) 1a receptor agonism reduced depressive symptoms with an acceptable side…

Patient CarePharmaceuticals and Medicines

Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”

By NS Healthcare Staff Writer

29 Sep 23

Unlocking the AI Revolution - A Symposium on the future of the Healthcare Industry and Diagnostic Imaging in…

Healthcare IT

Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept to Treat Adults with PAH

By NS Healthcare Staff Writer

29 Sep 23

If approved, sotatercept would be the first in its class, bringing a novel approach to address a rare…

Patient CarePharmaceuticals and Medicines

Sun Nuclear SunSCAN™ 3D Water Scanning System Receives CE Marking

By NS Healthcare Staff Writer

29 Sep 23

Faster, Hyper-Accurate Commissioning and Beam Scanning Solution Now Available in Countries Requiring CE Marking

Patient Care

British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day

By NS Healthcare Staff Writer

29 Sep 23

CaRi-Heart® Users share Excitement on Potential for Heart Attack Prediction and Prevention

Patient CareCardiovascular

Viatris, Ocuphire get FDA approval for Ryzumvi eye drops to treat mydriasis

By NS Healthcare Staff Writer

28 Sep 23

The FDA approval was supported by the data from the MIRA trial programme in which the percentage of…

Patient CarePharmaceuticals and Medicines

US FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis

By NS Healthcare Staff Writer

28 Sep 23

ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy

Patient CarePharmaceuticals and Medicines